IUHSA
HZNP

Itau Unibanco Holding S.A.’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-423
Closed -$26K – 668
2022
Q3 		$26K Hold
423
– – ﹤0.01% 426
2022
Q2 		$34K Sell
423
-4
-0.9% -$379 ﹤0.01% 347
2022
Q1 		$45K Buy
427
+8
+2% +$780 ﹤0.01% 319
2021
Q4 		$45K Buy
+419
New +$45.7K ﹤0.01% 304

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Itau Unibanco Holding S.A.'s HZNP Position: Q4 2022 in Review

Itau Unibanco Holding S.A. sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 423 shares — an estimated $26K sold.

Itau Unibanco Holding S.A. first reported a position in HZNP in Q4 2021 and held it in 4 quarters. The position peaked at $45K in Q1 2022. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

  • Itau Unibanco Holding S.A. reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 423 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $26K.
  • Itau Unibanco Holding S.A. first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 4 quarters.
  • Itau Unibanco Holding S.A.'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $45K in Q1 2022.
  • 615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2022, filed 9 Feb 2023.